Patrik Jeanmonod insider trades: Cytek Biosciences (CTKB) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patrik reports to the SEC
Open-market buys and sales
18 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 26, 2023 | CTKB | ↓ Sell | 3,000 | $9.50 | $29K | Direct | Dec 27, 2023 (1d) |
| Nov 24, 2023 | CTKB | ↓ Sell | 3,000 | $6.94 | $21K | Direct | Nov 27, 2023 (3d) |
| Oct 24, 2023 | CTKB | ↓ Sell | 3,000 | $4.68 | $14K | Direct | Oct 25, 2023 (1d) |
| Sep 25, 2023 | CTKB | ↓ Sell | 3,000 | $6.38 | $19K | Direct | Sep 26, 2023 (1d) |
| Aug 24, 2023 | CTKB | ↓ Sell | 3,000 | $7.69 | $23K | Direct | Aug 28, 2023 (4d) |
| Jul 24, 2023 | CTKB | ↓ Sell | 3,000 | $9.17 | $28K | Direct | Jul 25, 2023 (1d) |
| Jun 26, 2023 | CTKB | ↓ Sell | 3,000 | $7.96 | $24K | Direct | Jun 27, 2023 (1d) |
| May 24, 2023 | CTKB | ↓ Sell | 3,000 | $7.76 | $23K | Direct | May 25, 2023 (1d) |
| Apr 24, 2023 | CTKB | ↓ Sell | 3,000 | $10.24 | $31K | Direct | Apr 25, 2023 (1d) |
| Mar 24, 2023 | CTKB | ↓ Sell | 3,000 | $8.33 | $25K | Direct | Mar 24, 2023 (0d) |
| Feb 24, 2023 | CTKB | ↓ Sell | 3,000 | $11.05 | $33K | Direct | Feb 28, 2023 (4d) |
| Jan 24, 2023 | CTKB | ↓ Sell | 3,500 | $11.05 | $39K | Direct | Jan 25, 2023 (1d) |
| Dec 27, 2022 | CTKB | ↓ Sell | 3,500 | $9.77 | $34K | Direct | Dec 29, 2022 (2d) |
| Nov 25, 2022 | CTKB | ↓ Sell | 3,500 | $14.30 | $50K | Direct | Nov 28, 2022 (3d) |
| Oct 24, 2022 | CTKB | ↓ Sell | 3,500 | $15.16 | $53K | Direct | Oct 25, 2022 (1d) |
| Sep 26, 2022 | CTKB | ↓ Sell | 3,500 | $12.63 | $44K | Direct | Sep 28, 2022 (2d) |
| Aug 24, 2022 | CTKB | ↓ Sell | 3,500 | $13.45 | $47K | Direct | Aug 25, 2022 (1d) |
| Aug 1, 2022 | CTKB | ↓ Sell | 3,500 | $12.80 | $45K | Direct | Aug 3, 2022 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Patrik Jeanmonod's insider trades
Patrik Jeanmonod is Chief Financial Officer at Cytek Biosciences (CTKB). Since Aug 1, 2022, Patrik has reported no open-market purchases and 18 sales worth $581K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include option exercises (10 filings), shares withheld for taxes (9 filings), grants and awards (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CTKB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.